China Pharma Holdings, Inc. (CPHI) dividend history

CPHINYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30

$0.54−0.01 (-1.43%)

Close on Nov 11, 2026Market cap $23.37MP/E –Yield –

Dividends

No dividend per share appears in China Pharma's annual filings since fiscal 2010.

Parsed from the XBRL in China Pharma's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Apr 15, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CPHI.

Revenue growth-11.0% · median 3825.8%

Gross margin11.8% · median 33.7%

Operating margin-111.8% · median -692.4%

Net margin-114.3% · median 1834.7%

Advertisement
300 × 250

See a number that looks wrong?